iBrands Corporation Inc. (OTC-IBRC) Announces New CEO

Irvine, CA, March 11, 2016 (Newswire.com) - iBrands Corporation Inc. (OTC-IBRC), a holding company that acquires and operates niche market brands having unique market positioning with upside, today announces a new CEO, Michael Ogburn, as well as a new Board of Directors.

Michael Ogburn brings over 20 years of business ownership, financial risk management and financial analysis. He has had seats on several boards as well. “I’m very excited about the Board we put together. From Asset Management to the CEO for a chain of major hospitals. We have a very experienced, diversified team.”

"Our focus with iBrands, is to acquire and operate exceptional brands that have a durable, competitive advantage, that will ultimately reward long term investors of iBrands."

Michael Ogburn, CEO

“Our focus with iBrands, is to acquire and operate exceptional brands that have a durable, competitive advantage, that will ultimately reward long term investors of iBrands.” States Michael Ogburn, CEO of iBrands Corporation. Ogburn went on to further state, we are actively working on several acquisitions that are undervalued and possess great upside with operational execution.

iBrands is now focused on getting their company current with filings. “We hired a new legal team as well as a new CPA firm and are working swiftly to get the company current.” Ogburn stated.

iBrands has also opened a new Corporate Office with new contact info. It is as follows:

iBrands Corporation Inc.

18662 MacAurthur Blvd #200

Irvine, CA. 92612

949-440-3232

About iBrands Corporation, Inc.:

iBrands Corporation Inc. (“IBRC”), is a publicly traded holding company that acquires and operates niche market brands having unique market positioning with substantial upside. Our strategy is executed through the acquisition of proprietary brands having unique market niches with substantial upside growth and providing strong management. For further information, please contact the Company at: www.iBrandscorporation.com

Safe Harbor Statement:

This press release may contain forward looking statements and or observations which are based on current expectations, forecasts, and assumptions that involve risks as well as uncertainties that could cause actual outcomes and results to differ materially from those anticipated or expected, including statements related to the amount and timing of expected revenues as well as any payment of dividends on our stock, statements related to our financial performance, expected income, distributions, and future growth for upcoming quarterly and annual periods. These risks and uncertainties include but not limited to information as contained within the Company’s most current quarterly reports, annual reports, and or other such filings as may be accessed through the OTCBB website. Furthermore, the Company disclaims any intention or obligation to update or revise any such forward looking statements, whether as a result of new information, future events, or otherwise. We have incurred and will continue to incur significant expenses in our expansion of our existing as well as new product lines noting there is no assurance that we will generate enough revenues to offset those costs.  Additional product offerings may expose us to additional legal and regulatory costs and unknown exposure(s) based upon the variables as associated with the general business channel we are operating in, the impact of which cannot be predicted at this time including risks as associated with our product and recent FDA pronouncements. Additionally, our 1-A registration statement will generate additional free trading shares to the marketplace at a pre-determined price which may impact our share pricing within the OTC marketplace in a manner that we cannot predict.

Investor Contact: (949) 440-3232